Cellphire has developed a proprietary method for the long-term stabilization of
platelets in the dry state.
Thrombosomes® are currently in a Phase 1 clinical trial. Learn more.
For more Cellphire product development efforts, visit the Our Technology page.
News Releases
October 24, 2019 - Data from a phase 1, open-label, multi-center safety trial of lyophilized platele...Read More »
July 18, 2019 – Cellphire, Inc., the global leader in long-term cell stabilization and storage of ...Read More »
May 15, 2019 – Cellphire, Inc., the global leader in long-term stabilization and storage of platel...Read More »